NEW YORK, Dec 4 - Proteome Systems and Shimadzu said Monday they would jointly establish proteomics facilities in Sydney, Australia, and Boston, extending an alliance they originally formed earlier this year.
The companies’ joint proteomics efforts will rely on advanced sample preparation technologies and chemical printers that have been jointly developed by Proteome Systems and Shimadzu. These will be interfaced with AXIMA MALDI-TOF mass spectrometers, manufactured by Shimadzu’s Kratos Analytical subsidiary.
Shimadzu is also planning to implement the proteomics platform within its Kyoto facilities in 2001.
Under the terms of the partnership, Shimadzu and Proteome Systems will jointly develop new proteomics tools that will help to automate protein analysis. The companies said they expect to launch their first system around August 2001.
The companies are also considering incorporating Proteome Systems’ Glycosite analysis tools into the proteomics tools Shimadzu is developing.
“The goal is to develop an integrated platform of instruments for high level protein and glycoprotein characterization,” Proteome Systems said in a statement.
Neither company was immediately available for comment.
Shimadzu, a 125-year-old Japanese firm, manufactures scientific instruments. It recently released a high-throughput DNA sequencer as part of its efforts to establish a foothold in the genomics sector.Proteome Systems of Australia develops high-throughput proteomics platforms and develops bioinformatics tools for proteomics. The company has more than 60 employees in Sydney and Boston.